A preliminary study of PEFR monitoring in patients with chronic cough

Lung

Volumn 182, Issue 5, 2004, Pages 285-295

  Sano, T ^a   Ueda, H ^a   Bando, H ^a  

^a TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Chronic cough; Cough variant asthma; Peak expiratory flow rate; Suplatast tosilate

Indexed keywords

ANTITUSSIVE AGENT; BECLOMETASONE DIPROPIONATE; BRONCHODILATING AGENT; CLARITHROMYCIN; CORTICOSTEROID; CYTOKINE RECEPTOR ANTAGONIST; PREDNISOLONE; PROCATEROL; SUPLATAST TOSYLATE; THEOPHYLLINE;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CALCULATION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; COUGH VARIANT ASTHMA; COUGHING; CYTOKINE PRODUCTION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HOSPITAL; HUMAN; HUMAN CELL; LUNG FUNCTION TEST; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; TH2 CELL; THORAX RADIOGRAPHY; TREATMENT OUTCOME; WHEEZING;

ADULT; AGED; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHRONIC DISEASE; CIRCADIAN RHYTHM; COUGH; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; RESPIRATORY FUNCTION TESTS;

EID: 14944369745     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-004-2510-7     Document Type: Article

References (27)

1. RS Irwin LP Boulet MM Cloutier 1998 Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians Chest 114 Suppl 133 181
2. WM Corrao SS Braman RS Irwin 1979 Chronic cough as the sole presenting manifestation of bronchial asthma N Engl J Med 300 633 637
3. ER McFadden Jr 1975 Exertional dyspnea and cough as preludes to acute attacks of bronchial asthma N Engl J Med 292 555 559
4. MR Hetzel TJ Clark 1980 Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate Thorax 35 732 738
5. Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report. National Heart, Lung, and Blood Institutes (1995) Publication No. 95:3659
6. H Yamaya Y Basaki M Togawa M Kojima M Kiniwa N Matuura 1995 Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agents Life Sci 56 1647 1654
7. Y Yanagihara M Kiniwa K Ikizawa T Shida N Matuura A Koda 1993 Suppression of IgE production by IPD-1157T (suplatast tosilate), a new dimethylsulfonium agent: regulation of human IgE response Jpn J Pharmacol 61 31 39
8. A Koda Y Yanagihara N Matsuura 1991 IPD-1151T: a prototype drag of IgE antibody synthesis modulation Agents Actions (Suppl) 34 369 378
9. J Tamaoki K Takeyama K Aoshiba J Nakata K Nishimura A Nagai 2003 A Th2 cytokine inhibitor for airway inflammation in mild asthma J Allergy Clin Immunol 111 197 198
10. T Sano Y Nakamura H Yanagawa H Bando A Nii S Yoshida S Sano the Higashishikoku Astma Research Group 2003 Add-on effects of suplatast tosilate in bronchial asthma patients treated with inhaled corticosteroids Lung 181 227 235
11. T Miyamoto 1994 Bronchial Asthma Severity Judgment Criteria-Reviewing Committee Report Jpn J Allergol 43 71 80 (in Japanese)
12. S Makino S Kobayashi T Miyamoto 1982 Standard methods of provocation tests for asthma and hypersensitivity pneumonitis Jpn J Allergol 31 1074 (in Japanese)
13. T Takishima T Sasaki K Takahashi H Sasaki T Nakamura 1972 Direct-writing recorder of the flow-volume curve and its clinical application Chest 61 262 266
14. A Bhowmik TA Seemungal RJ Sapsford JL Devalia JA Wedzicha 1998 Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease Thorax 53 953 956
15. PG Gibson J Dolovich J Denburg EH Ramsdale FE Hargreave 1989 Chronic cough: eosinophilic bronchitis without asthma Lancet 1 1346 1348
16. RS Irwin FJ Curley CL French 1990 Chronic cough. The spectrum and frequency of causes, key component of the diagnostic evaluation, and outcome of specific therapy Am Rev Respir Dis 141 640 647
17. M Fujimura Y Kamio T Hashimoto T Matsuda 1994 Cough receptor sensitivity and bronchial responsiveness in patients with only chronic nonproductive cough: in view of bronchodilator therapy J Asthma 31 463 472
18. JJ Quackenboss MD Lebowits M Krzyzanowski 1991 The normal range of diurnal changes in peak expiratory flow rates. Relationship to symptoms and respiratory disease Am Rev Respir Dis 143 323 330
19. T Todisco V Grassi CA Sorbini 1980 Circadian rhythms of respiratory functions in asthmatics Respiration 40 128 135
20. LR Bagg DT Hughes 1980 Diurnal variation in peak expiratory flow in asthmatics Eur J Respir Dis 61 298 302
21. G Ryan KM Latimer J Dolovich FE Hargreave 1982 Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre Thorax 37 423 429
22. K Tokuyama M Shigeta S Maeda K Takei M Hoshino A Morikawa 1998 Diurnal variation of peak expiratory flow in children with cough variant asthma J Asthma 35 225 229
23. M Turner-Warwick 1997 On observing patterns of airflow obstruction in chronic asthma Br J Dis Chest 71 73 86
24. CK Connolly 1979 Diurnal rhythms in airway obstruction Br J Dis Chest 73 357 366
25. Y Sano T Mitamoto S Mikino 1997 Anti-inflammatory effect of suplatast tosilate on mild asthma Chest 112 862 863
26. J Tamaoki M Kondo N Sakai 2000 Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomized study Lancet 356 273 278
27. T Shioya M Satake M Sano 2002 Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma Eur J Clin Pharmacol 58 171 176